- Home
- MBLY vs CRL Comparison
MBLY vs CRL Comparison
Compare MBLY & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBLY | CRL |
|---|---|---|
| Founded | 1999 | 1947 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.0B |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MBLY | CRL |
|---|---|---|
| Price | $10.63 | $202.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | $18.71 | ★ $193.17 |
| AVG Volume (30 Days) | ★ 4.2M | 705.8K |
| Earning Date | 01-29-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,938,000,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $15.96 | N/A |
| Revenue Next Year | $7.51 | $1.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.61 | N/A |
| 52 Week Low | $10.04 | $91.86 |
| 52 Week High | $22.51 | $205.00 |
Technical Indicators
Market Signals| Indicator | MBLY | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 67.67 |
| Support Level | $10.08 | $201.04 |
| Resistance Level | $10.40 | $205.00 |
| Average True Range (ATR) | 0.38 | 4.49 |
| MACD | 0.06 | 0.38 |
| Stochastic Oscillator | 30.54 | 83.81 |
Price Performance
Historical ComparisonAbout MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.